Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
0.8457
-0.0144 (-1.67%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $1.52 million as of August 3, 2026. Its market cap has decreased by -65.86% in one year.
Market Cap
1.52M
Enterprise Value
-3.01M
1-Year Change
-65.86%
Ranking
Category
Stock Price
$0.85
ChartMarket Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $1.52M, a decrease of -99.02%. That is a compound annual growth rate of -36.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.52M | -41.68% |
| Dec 31, 2025 | 2.60M | 12.38% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oragenics | 2.26M |
| Decoy Therapeutics | 2.19M |
| Azitra | 2.15M |
| Moleculin Biotech | 2.13M |
| Virax Biolabs Group | 2.09M |
| Calidi Biotherapeutics | 1.99M |
| Matinas BioPharma Holdings | 1.88M |
| CDT Equity | 1.85M |